Reducing Risk for Thrombosis in Patients With Lung Cancer

Researchers have examined whether treatment with lazertinib-amivantamab entails an increased risk of venous thromboembolism in patients with advanced or metastatic non–small cell lung cancer.
Medscape Medical News

source https://www.medscape.com/viewarticle/993428?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?